Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
about
Pharmacological strategies for detoxification.The role of guanfacine as a therapeutic agent to address stress-related pathophysiology in cocaine-dependent individuals.The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence.Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?Guanfacine enhances inhibitory control and attentional shifting in early abstinent cocaine-dependent individualsMoxonidine for tramadol withdrawal symptoms during detoxification.Newer approaches to opioid detoxification.Selective review and commentary on emerging pharmacotherapies for opioid addiction.Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia.Preclinical evidence of new opioid modulators for the treatment of addiction.Role of α2-agonists in the treatment of acute alcohol withdrawal.Update on pharmacotherapy for treatment of opioid use disorder.Low Doses of Allyphenyline and Cyclomethyline, Effective against Morphine Dependence, Elicit an Antidepressant-like Effect.Time-dependent neuronal changes associated with craving in opioid dependence: an fMRI study.
P2860
Q33582092-F2843099-C737-4367-9E53-7F0C7DC5F945Q33598487-B8C1B78B-2DE4-4E9E-B5D7-B93E5A7F028BQ33870389-EFF5CE81-BDC5-4AC5-8B5B-B2F3EF0577D8Q34613312-8A546C89-FCE6-4D39-BA5B-A00B05C653FDQ35608560-DF52D2DB-911C-4380-A9C9-5E0B690AD335Q35844304-72F5F2B5-1BC3-411E-A11B-0CCD3E57B6C8Q37314261-A6A73AF0-78AF-425B-8786-E671FEA6DAADQ37355286-7A7E9A62-F756-4A75-B50C-AA08C65F2ABEQ37677214-9F28270F-2FD1-4010-94DA-487F1B5747FCQ37772519-FD8E5E5D-7041-4B0A-8977-3A1A13608085Q37869277-2273C0E8-66B2-4504-B722-6F8ABBF79074Q38979423-4A0906BB-97FC-4161-BD0C-814A77A6B9E5Q39734497-1A580B1E-9FE6-40BA-BD45-FDDF73513A99Q44349141-BFD829DE-D983-4DA3-A70B-B9E4EDC0F8B9
P2860
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@ast
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@en
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@nl
type
label
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@ast
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@en
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@nl
prefLabel
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@ast
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@en
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@nl
P2093
P2860
P356
P1476
Lofexidine, an {alpha}2-receptor agonist for opioid detoxification.
@en
P2093
Brooke L Honey
Emily C Gish
Jamie L Miller
Peter N Johnson
P2860
P304
P356
10.1345/APH.1M347
P407
P577
2009-12-29T00:00:00Z